![L-Lysine, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate (1:1)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F305347-l-lysine-2-1-phenylmethyl-1h-indazol-3-yl-oxy-acetate-1-1.webp&w=3840&q=75)
CAS 81919-14-4: L-Lysine, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate (1:1)
Formula:C16H14N2O3·C6H14N2O2
InChI:InChI=1S/C16H14N2O3.C6H14N2O2/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12;7-4-2-1-3-5(8)6(9)10/h1-9H,10-11H2,(H,19,20);5H,1-4,7-8H2,(H,9,10)/t;5-/m.0/s1
InChI key:InChIKey=OCOCFNMFLNFNIA-ZSCHJXSPSA-N
SMILES:C(N1C=2C(C(OCC(O)=O)=N1)=CC=CC2)C3=CC=CC=C3.[C@H](CCCCN)(C(O)=O)N
Synonyms:- 2,6-diammoniohexanoate [(1-benzyl-1H-indazol-3-yl)oxy]acetate
- <span class="text-smallcaps">L</span>-Lysine, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate (1:1)
- <span class="text-smallcaps">L</span>-Lysine, mono[[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate]
- Acetic acid, [[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-, compd. with <span class="text-smallcaps">L</span>-lysine (1:1)
- Af 1934
- Bendaline
- Bendazac <span class="text-smallcaps">L</span>-lysine salt
- Bendazac lysine
- Bendazac lysine salt
- Bendazaclysine
- L-Lysine-(1-benzyl-1H-indazol-3-yloxy)acetic acid
- See more synonyms
Sort by
Found 9 products.
(S)-2,6-Diaminohexanoic Acid 2-((1-Benzyl-1H-Indazol-3-Yl)Oxy)Acetic Acid Salt
CAS:(S)-2,6-Diaminohexanoic Acid 2-((1-Benzyl-1H-Indazol-3-Yl)Oxy)Acetic Acid SaltPurity:98%Molecular weight:428.48g/molBendazac L-lysine
CAS:Bendazac L-lysine (Bendazaco lisina) is an agent introduced for the management of cataracts, protecting the level of vision in patients.Formula:C22H28N4O5Purity:99.85%Color and Shape:WhiteMolecular weight:428.48L-Lysine, mono[[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate]OTHER CA INDEX NAMES:Acetic acid, [[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-, compd. withL-lysine (1:1)
CAS:Formula:C22H28N4O5Purity:98%Color and Shape:SolidMolecular weight:428.4815Bendazac L-lysine
CAS:Controlled ProductBendazac L-lysine is a coumarin derivative that is used in pharmaceutical preparations for the treatment of diabetic neuropathy. It has been shown to increase the levels of growth factors, such as insulin-like growth factor-1 and vascular endothelial growth factor, in diabetic patients. Bendazac L-lysine can be prepared by high performance liquid chromatography (HPLC) using preparative reverse phase HPLC. The fluorescence spectrometry of bendazac L-lysine was measured at 230 nm with excitation at 220 nm and emission at 255 nm. Bendazac L-lysine has also been shown to have an absorption enhancer effect on lysine, a necessary amino acid for collagen synthesis.Formula:C22H28N4O5Purity:Min. 95%Molecular weight:428.48 g/molBendazac L-Lysine
CAS:Controlled ProductFormula:C16H14N2O3·C6H14N2O2Color and Shape:NeatMolecular weight:428.481
![L-Lysine, mono[[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetate]OTHER CA INDEX NAMES:Acetic acid, [[…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA00ID7Q.jpg&w=3840&q=75)
